NCT05080699View on ClinicalTrials.gov

Evaluating Benefit of Peptide Based Diet in Obese HEN Patients

NAEnrolling by invitationINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

March 25, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Obesity
Interventions
DIETARY_SUPPLEMENT

Peptamen Intense VHP, Nestlé Health Science, Switzerland

An enteral formula containing hydrolyzed whey protein, maltodextrin, long-chain triglycerides, medium chain triglycerides (MCT), vitamins and minerals. Compared to standard enteral formula, Peptamen Intense is higher in protein (37 kcal%) and lower in carbohydrates (29 kcal%). The energy content is 1.0 kcal/mL.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT05080699 - Evaluating Benefit of Peptide Based Diet in Obese HEN Patients | Biotech Hunter | Biotech Hunter